← FDA Drug Approvals (Drugs@FDA)
CYCLOBENZAPRINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2024-08-27
Drug application
- FDA Application #
ANDA214732- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CYCLOBENZAPRINE HYDROCHLORIDE
- Generic name
- Cyclobenzaprine Hydrochloride
- Active ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- NOVAST LABS
- First approval
- 2024-08-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown